Nb |
Pat |
Sex |
Age |
Primary disease |
BiP Treatment |
Length of BiP treatment (months) |
Triggering cause of BRONJ |
Osteonecrotic area |
ONJ
Classification |
Time between start of BiP intake and BRONJ diagnosis (months) |
Time between end of BiP intake and BRONJ diagnosis (months) |
Time between surgery and last follow-up (months) |
1 |
MA |
F |
79 |
Breast cancer |
Zoledronate (Zometa) |
15 |
Extraction of # 43, 44 |
Mandible, Left anterior area |
ONJ 3 |
39 |
0.5 |
27, deceased |
2 |
IG |
F |
77 |
Osteoporosis |
Alendronate (Fosavance) |
35 |
Extraction of # 46 |
Mandible, Posterior at # 46 |
ONJ 2/3 |
88 |
0 |
38 |
3 |
DF |
M |
68 |
Multiple myeloma |
Zoledronate (Zometa) |
38 |
Extraction of # 36,37, 46,47 |
Mandible, Bilat. posterior at # 36,37 & 46,47 |
ONJ 3 |
110 |
6 |
32 |
4 |
BA |
M |
77 |
Prostate cancer |
Zoledronate (Zometa) |
33 |
Traumatic ill-fitted prosthesis |
Mandible, Anterior at # 33,34 |
ONJ 2 |
90 |
3 |
26 |
5 |
SM |
F |
81 |
Osteoporosis |
Alendronate (Fosavance) |
32 |
Extraction of # 11,12 |
Maxilla, Anterior at # 11,12 |
ONJ 2 |
80 |
0 |
23 |
6 |
GP |
M |
60 |
Multiple myelome |
Zoledronate (Zometa) |
20 |
Extraction of # 16,17 |
Maxilla, Posterior at # 16,17 |
ONJ 3 |
53 |
1 |
15 |
7 |
NL |
F |
69 |
Osteoporosis |
Alendronate (Alendros 70) |
70 |
Extraction of # 47 |
Mandible, Posterior at # 47 |
ONJ 2 |
183 |
3 |
14 |
8 |
MS |
F |
59 |
Multiple myelome |
Zoledronate (Zometa) |
13 |
Extraction of # 43, 44 |
Mandible, Left anterior area |
ONJ 2 |
35 |
1 |
13 |